M&A Deal Summary |
|
|---|---|
| Date | 2019-07-01 |
| Target | LinkSPINE |
| Sector | Medical Products |
| Buyer(s) | Celling Biosciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows users to regulate and select a desired cell type through a patented collection window and integrated ultra-filtration system. Celling is a transformative leader innovating cellular therapy by integrating excellence in research, medical education, advocacy, and product development. Celling Biosciences is based in Austin, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2019 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-04 |
ThermiGen
Irving, Texas, United States ThermiGen LLC is a global manufacturer of temperature controlled radiofrequency technology. The company's flagship product is ThermiRF, a platform technology that uses temperature as an endpoint for various minimally and non-invasive applications (ThermiTight, ThermiRase, ThermiSmooth Face, ThermiVa, etc.). Thermi also offers the Thermi250 device as the newest innovative RF for the body. Founded in 2012, Thermi is a US based company with its headquarters in Irving, Texas, and R&D in Boston, MA. |
Buy | - |
